The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Advances in De Novo Drug Design: From Conventional to Machine Learning Methods
Open accessAbstract
De novo drug design is a computational approach that generates novel molecular structures from atomic building blocks with no a priori relationships. Conventional methods include structure-based and ligand-based design, which depend on the properties of the active site of a biological target or its known active binders, respectively. Artificial intelligence, including ma-chine learning, is an emerging field that has positively impacted the drug discovery process. Deep reinforcement learning is a subdivision of machine learning that combines artificial neural networks with reinforcement-learning architectures. This method has successfully been em-ployed to develop novel de novo drug design approaches using a variety of artificial networks including recurrent neural networks, convolutional neural networks, generative adversarial networks, and autoencoders. This review article summarizes advances in de novo drug design, from conventional growth algorithms to advanced machine-learning methodologies and high-lights hot topics for further development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Gradient-based learning applied to document recognition
Lecun, Y., Bottou, L., Bengio, Y., & Haffner, P. (1998) · Proceedings of the IEEE · doi:10.1109/5.726791 · Cited by 58,805
Genetic algorithms in search, optimization, and machine learning
(1989) · Choice Reviews Online · doi:10.5860/choice.27-0936 · Cited by 49,010
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Learning Phrase Representations using RNN Encoder–Decoder for Statistical Machine Translation
Cho, K., van Merrienboer, B., Gulcehre, C., Bahdanau, D., Bougares, F., Schwenk, H., & Bengio, Y. (2014) · Proceedings of the 2014 Conference on Empirical Methods in Natural Language Processing (EMNLP) · doi:10.3115/v1/d14-1179 · Cited by 25,545
Pan, S. J., & Yang, Q. (2010) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2009.191 · Cited by 23,387
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Sequence to Sequence Learning with Neural Networks
Sutskever, I., Vinyals, O., & Le, Q. V. (2014) · arXiv · doi:10.48550/arxiv.1409.3215 · Cited by 17,766
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Learning Phrase Representations using RNN Encoder-Decoder for Statistical Machine Translation
Cho, K., van Merrienboer, B., Gulcehre, C., Bahdanau, D., Bougares, F., Schwenk, H., & Bengio, Y. (2014) · arXiv · doi:10.48550/arxiv.1406.1078 · Cited by 3,317
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Deep learning for healthcare: review, opportunities and challenges
Miotto, R., Wang, F., Wang, S., Jiang, X., & Dudley, J. T. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx044 · Cited by 3,076 · cited 1×
“In addition, DL has been employed for the development of analysis approaches in data-driven fields such as biomedicine and healthcare [78,79].”
MethodGaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
A Critical Review of Recurrent Neural Networks for Sequence Learning
Lipton, Z. C., Berkowitz, J. A., & Elkan, C. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1506.00019 · Cited by 1,996
Ertl, P., & Schuffenhauer, A. (2009) · Journal of Cheminformatics · doi:10.1186/1758-2946-1-8 · Cited by 1,939
Generative adversarial network in medical imaging: A review
Yi, X., Walia, E., & Babyn, P. (2019) · Medical Image Analysis · doi:10.1016/j.media.2019.101552 · Cited by 1,863
Unsupervised Learning of Video Representations using LSTMs
Srivastava, N., Mansimov, E., & Salakhutdinov, R. (2015) · arXiv · doi:10.48550/arxiv.1502.04681 · Cited by 1,861
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.
Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,703
Makhzani, A., Shlens, J., Jaitly, N., Goodfellow, I., & Frey, B. (2015) · arXiv · doi:10.48550/arxiv.1511.05644 · Cited by 1,579
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573 · cited 1×
“Examples of DRL-based de novo drug design include the development of adenosine A2A receptor ligands [83], rapid identification of potent DDR1 kinase inhibitors [154], and the development of a large number of new BACE1 inhibitors, which is an enzyme involved in Alzheimer’s disease [118].”
BackgroundGenerating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Molecular de-novo design through deep reinforcement learning
Olivecrona, M., Blaschke, T., Engkvist, O., & Chen, H. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0235-x · Cited by 1,324
Burley, S. K., Berman, H. M., Bhikadiya, C., Bi, C., Chen, L., Di Costanzo, L., Christie, C., Dalenberg, K., Duarte, J. M., Dutta, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1004 · Cited by 1,243
A Review on Generative Adversarial Networks: Algorithms, Theory, and Applications
Gui, J., Sun, Z., Wen, Y., Tao, D., & Ye, J. (2023) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2021.3130191 · Cited by 1,231
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,182
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Computer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948
Generalization of back-propagation to recurrent neural networks
Pineda, F. J. (1987) · Physical Review Letters · doi:10.1103/physrevlett.59.2229 · Cited by 931 · cited 1×
“A recurrent neural network (RNN) is an artificial neural network architecture that employs cyclic connections between neurons [86,87].”
BackgroundMuratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910 · cited 1×
“Advances in high-throughput screening of commercial or in-house compound libraries have significantly enhanced the discovery and development of small-molecule drug candidates [4].”
BackgroundGuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Lalmuanawma, S., Hussain, J., & Chhakchhuak, L. (2020) · Chaos, Solitons & Fractals · doi:10.1016/j.chaos.2020.110059 · Cited by 845
The computer program LUDI: A new method for the de novo design of enzyme inhibitors
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 835
LSTM recurrent networks learn simple context-free and context-sensitive languages
Gers, F. A., & Schmidhuber, E. (2001) · IEEE Transactions on Neural Networks · doi:10.1109/72.963769 · Cited by 722
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701
Advancing drug discovery via artificial intelligence
Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.004 · Cited by 654
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587
Molecular representations in AI-driven drug discovery: a review and practical guide
David, L., Thakkar, A., Mercado, R., & Engkvist, O. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00460-5 · Cited by 587 · cited 1×
“Depending on the type of artificial network, the input layer might consist of SMILES or graphs of molecules [84].”
BackgroundFunctionality maps of binding sites: A multiple copy simultaneous search method
Miranker, A., & Karplus, M. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110104 · Cited by 544
Ton, A., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020) · Molecular Informatics · doi:10.1002/minf.202000028 · Cited by 517
LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00126217 · Cited by 459
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455
Generative Recurrent Networks for De Novo Drug Design
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 441
Molecular generative model based on conditional variational autoencoder for de novo molecular design
Lim, J., Ryu, S., Kim, J. W., & Kim, W. Y. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0286-7 · Cited by 421
Méndez-Lucio, O., Baillif, B., Clevert, D.-A., Rouquié, D., & Wichard, J. (2020) · Nature Communications · doi:10.1038/s41467-019-13807-w · Cited by 419
Graph convolutional networks for computational drug development and discovery
Sun, M., Zhao, S., Gilvary, C., Elemento, O., Zhou, J., & Wang, F. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz042 · Cited by 413
A de novo molecular generation method using latent vector based generative adversarial network
Prykhodko, O., Johansson, S. V., Kotsias, P.-C., Arús-Pous, J., Bjerrum, E. J., Engkvist, O., & Chen, H. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0397-9 · Cited by 402
The Synthesizability of Molecules Proposed by Generative Models
Gao, W., & Coley, C. W. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00174 · Cited by 394
Unrolled Generative Adversarial Networks
Metz, L., Poole, B., Pfau, D., & Sohl‐Dickstein, J. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1611.02163 · Cited by 382
SCScore: Synthetic Complexity Learned from a Reaction Corpus
Coley, C. W., Rogers, L., Green, W. H., & Jensen, K. F. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00622 · Cited by 381
Multi-objective de novo drug design with conditional graph generative model
Li, Y., Zhang, L., & Liu, Z. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0287-6 · Cited by 376
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Putin, E., Asadulaev, A., Ivanenkov, Y., Aladinskiy, V., Sanchez-Lengeling, B., Aspuru-Guzik, A., & Zhavoronkov, A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 372
Target validation of G-protein coupled receptors
Wise, A., Gearing, K., & Rees, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02131-6 · Cited by 359
Homology modeling in drug discovery: Overview, current applications, and future perspectives
Muhammed, M. T., & Aki‐Yalcin, E. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13388 · Cited by 358
Deep learning in drug discovery: opportunities, challenges and future prospects
Lavecchia, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.07.006 · Cited by 353
Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350
Lenselink, E. B., ten Dijke, N., Bongers, B., Papadatos, G., van Vlijmen, H. W. T., Kowalczyk, W., IJzerman, A. P., & van Westen, G. J. P. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0232-0 · Cited by 334
LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design
Wang, R., Gao, Y., & Lai, L. (2000) · Journal of Molecular Modeling · doi:10.1007/s0089400060498 · Cited by 287
Bai, Q., Tan, S., Xu, T., Liu, H., Huang, J., & Yao, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa161 · Cited by 287
Predictive in silico modeling for hERG channel blockers
Aronov, A. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03278-7 · Cited by 267
Efficient multi-objective molecular optimization in a continuous latent space
Winter, R., Montanari, F., Steffen, A., Briem, H., Noé, F., & Clevert, D.-A. (2019) · Chemical Science · doi:10.1039/c9sc01928f · Cited by 260
A Review on Generative Adversarial Networks: Algorithms, Theory, and Applications
Gui, J., Sun, Z., Wen, Y., Tao, D., & Ye, J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2001.06937 · Cited by 253
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Hartenfeller, M., Zettl, H., Walter, M., Rupp, M., Reisen, F., Proschak, E., Weggen, S., Stark, H., & Schneider, G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002380 · Cited by 251 · cited 1×
“Examples of ligand-based de novo drug design tools include TOPAS [37], SYNOPSIS [38], and DOGS [39].”
MethodDe novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
Schneider, G., Lee, M.-L., Stahl, M., & Schneider, P. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008184403558 · Cited by 251
Predicting Retrosynthetic Reactions Using Self-Corrected Transformer Neural Networks
Zheng, S., Rao, J., Zhang, Z., Xu, J., & Yang, Y. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00949 · Cited by 249
Quantum Machine Learning in Chemical Compound Space
von Lilienfeld, O. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201709686 · Cited by 245
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
Keshavarzi Arshadi, A., Webb, J., Salem, M., Cruz, E., Calad-Thomson, S., Ghadirian, N., Collins, J., Diez-Cecilia, E., Kelly, B., Goodarzi, H., et al. (2020) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2020.00065 · Cited by 244
Rifaioglu, A. S., Nalbat, E., Atalay, V., Martin, M. J., Cetin-Atalay, R., & Doğan, T. (2020) · Chemical Science · doi:10.1039/c9sc03414e · Cited by 240
Deep Reinforcement Learning for Multiparameter Optimization in de novo Drug Design
Ståhl, N., Falkman, G., Karlsson, A., Mathiason, G., & Boström, J. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00325 · Cited by 238
Finding temporal structure in music: blues improvisation with LSTM recurrent networks
Eck, D., & Schmidhuber, J. (2003) · Proceedings of the 12th IEEE Workshop on Neural Networks for Signal Processing · doi:10.1109/nnsp.2002.1030094 · Cited by 236
The Next Era: Deep Learning in Pharmaceutical Research
Ekins, S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2029-7 · Cited by 235
Kotsias, P.-C., Arús-Pous, J., Chen, H., Engkvist, O., Tyrchan, C., & Bjerrum, E. J. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0174-5 · Cited by 234
Shape-Based Generative Modeling for de Novo Drug Design
Skalic, M., Jiménez, J., Sabbadin, D., & De Fabritiis, G. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00706 · Cited by 229
Bidirectional Molecule Generation with Recurrent Neural Networks
Grisoni, F., Moret, M., Lingwood, R., & Schneider, G. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00943 · Cited by 229
SYNOPSIS: SYNthesize and OPtimize System in Silico
Vinkers, H. M., de Jonge, M. R., Daeyaert, F. F. D., Heeres, J., Koymans, L. M. H., van Lenthe, J. H., Lewi, P. J., Timmerman, H., Van Aken, K., & Janssen, P. A. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030809x · Cited by 220
Identifying and measuring developments in artificial intelligence: Making the impossible possible
Baruffaldi, S. H., Beuzekom, B. V., Dernis, H., Harhoff, D., Rao, N., Rosenfeld, D., & Squicciarini, M. (2020) · OECD science, technology and industry working papers · doi:10.1787/5f65ff7e-en · Cited by 219
Adversarial Threshold Neural Computer for Molecular de Novo Design
Putin, E., Asadulaev, A., Vanhaelen, Q., Ivanenkov, Y., Aladinskaya, A. V., Aliper, A., & Zhavoronkov, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01137 · Cited by 211
Eisen, M. B., Wiley, D. C., Karplus, M., & Hubbard, R. E. (1994) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340190305 · Cited by 210
Application of Artificial Intelligence in COVID-19 drug repurposing
Mohanty, S., Harun AI Rashid, M., Mridul, M., Mohanty, C., & Swayamsiddha, S. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.068 · Cited by 204
Multi-objective optimization methods in drug design
Nicolaou, C. A., & Brown, N. (2013) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2013.02.001 · Cited by 192
Bohacek, R. S., & McMartin, C. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00092a006 · Cited by 188
Machine learning for chemical discovery
Tkatchenko, A. (2020) · Nature Communications · doi:10.1038/s41467-020-17844-8 · Cited by 183
SPROUT: Recent developments in the de novo design of molecules
Gillet, V. J., Newell, W., Mata, P., Myatt, G., Sike, S., Zsoldos, Z., & Johnson, A. P. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00017a027 · Cited by 179
Bjerrum, E. J., & Sattarov, B. (2018) · Biomolecules · doi:10.3390/biom8040131 · Cited by 178
LEA3D: A Computer-Aided Ligand Design for Structure-Based Drug Design
Douguet, D., Munier-Lehmann, H., Labesse, G., & Pochet, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492296 · Cited by 165
De Novo Design at the Edge of Chaos: Miniperspective
Schneider, P., & Schneider, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01849 · Cited by 164
Automated De Novo Drug Design: Are We Nearly There Yet?
Schneider, G., & Clark, D. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814681 · Cited by 164
A review of reinforcement learning methodologies for controlling occupant comfort in buildings
Han, M., May, R., Zhang, X., Wang, X., Pan, S., Yan, D., Jin, Y., & Xu, L. (2019) · Sustainable Cities and Society · doi:10.1016/j.scs.2019.101748 · Cited by 162
Douguet, D., Thoreau, E., & Grassy, G. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008108423895 · Cited by 160
Evolutionary algorithms for de novo drug design – A survey
Devi, R. V., Sathya, S. S., & Coumar, M. S. (2014) · Applied Soft Computing · doi:10.1016/j.asoc.2014.09.042 · Cited by 152
The Advent of Generative Chemistry
Vanhaelen, Q., Lin, Y.-C., & Zhavoronkov, A. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00088 · Cited by 151
Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization
Dey, F., & Caflisch, A. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700424b · Cited by 148
AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2
Tang, B., He, F., Liu, D., He, F., Wu, T., Fang, M., Niu, Z., Wu, Z., & Xu, D. H. (2022) · Biomolecules · doi:10.3390/biom12060746 · Cited by 148
Evolutionary algorithms in computer-aided molecular design
Clark, D. E., & Westhead, D. R. (1996) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124503 · Cited by 144
DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning
Li, Y., Hu, J., Wang, Y., Zhou, J., Zhang, L., & Liu, Z. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00727 · Cited by 144
Clark, D. E., Frenkel, D., Levy, S. A., Li, J., Murray, C. W., Robson, B., Waszkowycz, B., & Westhead, D. R. (1995) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00117275 · Cited by 136
Gillet, V. J., Myatt, G. J., Zsoldos, Z., & Johnson, A. P. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174466 · Cited by 131
A genetic algorithm for structure-based de novo design
Pegg, S. C. ‐., Haresco, J. J., & Kuntz, I. D. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1014389729000 · Cited by 129
Generative Network Complex for the Automated Generation of Drug-like Molecules
Gao, K., Nguyen, D. D., Tu, M., & Wei, G. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00599 · Cited by 124
De Novo Drug Design Using Multiobjective Evolutionary Graphs
Nicolaou, C. A., Apostolakis, J., & Pattichis, C. S. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800308h · Cited by 120
CONCERTS: Dynamic Connection of Fragments as an Approach to de Novo Ligand Design
Pearlman, D. A., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950792l · Cited by 116
Dynamical Variational Autoencoders: A Comprehensive Review
Laurent Girin, B., Leglaive, S., Bie, X., Diard, J., Hueber, T., & Alameda-Pineda, X. (2021) · doi:10.1561/9781680839135 · Cited by 115
Analysis of the genetic algorithm method of molecular conformation determination
McGarrah, D. B., & Judson, R. (1993) · Journal of Computational Chemistry · doi:10.1002/jcc.540141115 · Cited by 113
Flux (1): A Virtual Synthesis Scheme for Fragment-Based de Novo Design
Fechner, U., & Schneider, G. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0503560 · Cited by 112
Compound Design by Fragment‐Linking
Ichihara, O., Barker, J. J., Law, R. J., & Whittaker, M. A. (2011) · Molecular Informatics · doi:10.1002/minf.201000174 · Cited by 111
Biologically Plausible Speech Recognition with LSTM Neural Nets
Graves, A., Eck, D., Beringer, N., & Schmidhuber, J. (2004) · Lecture notes in computer science · doi:10.1007/978-3-540-27835-1_10 · Cited by 109
Danziger, D. J., & Dean, P. M. (1989) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1989.0015 · Cited by 106
Liu, X., Ye, K., van Vlijmen, H., IJzerman, A. P., & van Westen, G. J. P. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0355-6 · Cited by 106
Afantitis, A., Melagraki, G., Koutentis, P. A., Sarimveis, H., & Kollias, G. A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.029 · Cited by 98
Self-citationKhemchandani, Y., O’Hagan, S., Samanta, S., Swainston, N., Roberts, T. J., Bollegala, D., & Kell, D. B. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00454-3 · Cited by 96
Machine Learning in Drug Discovery
Klambauer, G., Hochreiter, S., & Rarey, M. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00136 · Cited by 95
Kinaret, P., Serra, A., Federico, A., Kohonen, P. J., Nymark, P. E. H., Liampa, I., Ha, M. K., Choi, J., Jagiełło, K., Sanabria, N. M., et al. (2020) · Nanomaterials · doi:10.3390/nano10040750 · Cited by 81
Self-citationMultiobjective de novo drug design with recurrent neural networks and nondominated sorting
Yasonik, J. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00419-6 · Cited by 80
Tan, J., Cong, X. J., Hu, L., Wang, C. X., Jia, L., & Liang, X. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.004 · Cited by 75
Concept of Combinatorial De Novo Design of Drug‐like Molecules by Particle Swarm Optimization
Hartenfeller, M., Proschak, E., Schüller, A., & Schneider, G. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00672.x · Cited by 69
Mouchlis, V. D., Melagraki, G., Zacharia, L. C., & Afantitis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030703 · Cited by 69
Self-citationFederico, A., Serra, A., Ha, M. K., Kohonen, P. J., Choi, J., Liampa, I., Nymark, P. E. H., Sanabria, N. M., Cattelani, L., Fratello, M., et al. (2020) · Nanomaterials · doi:10.3390/nano10050903 · Cited by 61
Self-citationCruz‐Monteagudo, M., Borges, F., & Cordeiro, M. N. D. S. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20994 · Cited by 54
Graph Kernels for Molecular Similarity
Rupp, M., & Schneider, G. (2010) · Molecular Informatics · doi:10.1002/minf.200900080 · Cited by 49
Approaching Target Selectivity by De Novo Drug Design
Fischer, T., Gazzola, S., & Riedl, R. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1615435 · Cited by 49
Molecular Complexity Analysis of de Novo Designed Ligands
Boda, K., & Johnson, A. P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050054p · Cited by 48
A Deep-Learning View of Chemical Space Designed to Facilitate Drug Discovery
Maragakis, P., Nisonoff, H. M., Cole, B., & Shaw, D. E. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00321 · Cited by 48
In Silico Prediction of Drug Properties
Hutter, M. C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986709787002736 · Cited by 45
Multi-Objective Optimization Methods in De Novo Drug Design
Nicolaou, C. P., Kannas, C. C., & Loizidou, E. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712802762284 · Cited by 43
From flamingo dance to (desirable) drug discovery: a nature-inspired approach
Sánchez‐Rodríguez, A., Pérez‐Castillo, Y., Schürer, S. C., Nicolotti, O., Mangiatordi, G. F., Borges, F., Cordeiro, M. N. D. S., Tejera, E., Medina‐Franco, J. L., & Cruz‐Monteagudo, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.008 · Cited by 39
Packaging and Sharing Machine Learning Models via the Acumos AI Open Platform
Zhao, S., Talasila, M., Jacobson, G., Borcea, C., Aftab, S. A., & Murray, J. F. (2018) · International Conference on Machine Learning and Applications · doi:10.1109/icmla.2018.00135 · Cited by 38
Structure-based ligand design for flexible proteins: Application of new F-DycoBlock
Zhu, J., Fan, H., Liu, H., & Shi, Y. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1014817911249 · Cited by 36
Schneider, G. (2014) · Molecular Informatics · doi:10.1002/minf.201400034 · Cited by 36
Schüller, A., Suhartono, M., Fechner, U., Tanrikulu, Y., Breitung, S., Scheffer, U., Göbel, M., & Schneider, G. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9157-4 · Cited by 27
Pérez‐Castillo, Y., Sánchez‐Rodríguez, A., Tejera, E., Cruz‐Monteagudo, M., Borges, F., Cordeiro, M. N. D. S., Le‐Thi‐Thu, H., & Pham‐The, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192176 · Cited by 23
Wang, Y., Zhao, H., Brewer, J. T., Li, H., Lao, Y., Amberg, W., Behl, B., Akritopoulou‐Zanze, I., Dietrich, J. D., Lange, U. E. W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00295 · Cited by 23
EvoMD: An Algorithm for Evolutionary Molecular Design
Wong, S. S. Y., Luo, W., & Chan, K. C. C. (2010) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2010.100 · Cited by 20
Generative Adversarial Networks (GANs) Based Synthetic Sampling for Predictive Modeling
Barigye, S. J., de la Vega, J. M. G., & Pérez‐Castillo, Y. (2020) · Molecular Informatics · doi:10.1002/minf.202000086 · Cited by 20
Zhu, J., Yu, H. B., Fan, H., Liu, H., & Shi, Y. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011114307711 · Cited by 19
Multistep Reaction Based De Novo Drug Design: Generating Synthetically Feasible Design Ideas
Masek, B. B., Baker, D. S., Dorfman, R. J., Dubrucq, K., Francis, V. C., Nagy, S., Richey, B. L., & Soltanshahi, F. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00697 · Cited by 17
4.05 – Ligand-Based Approaches: Core Molecular Modeling
Leach, A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00246-7 · Cited by 14
Predicting Retrosynthetic Reaction using Self-Corrected Transformer Neural NetworksPreprint
Zheng, S., Rao, J., Zhang, Z., et al. (2019) · ChemRxiv · doi:10.26434/chemrxiv.8427776 · Cited by 10
Interpreting Shared Deep Learning Models via Explicable Boundary TreesPreprint
Wu, H., Wang, C., Yin, J., Lü, K., & Zhu, L. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1709.03730 · Cited by 6
Cited by
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 625
Nanotechnology and artificial intelligence to enable sustainable and precision agriculture
Zhang, P., Guo, Z., Ullah, S., Melagraki, G., Afantitis, A., & Lynch, I. (2021) · Nature Plants · doi:10.1038/s41477-021-00946-6 · Cited by 478
Self-citationReinvent 4: Modern AI–driven generative molecule design
Loeffler, H. H., He, J., Tibo, A., Janet, J. P., Voronov, A., Mervin, L. H., & Engkvist, O. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00812-5 · Cited by 319
Artificial intelligence for drug discovery: Resources, methods, and applications
Chen, W., Liu, X., Zhang, S., & Chen, S. (2023) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2023.02.019 · Cited by 273
Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed, M. T., & Aki-Yalcin, E. (2024) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 267
Metadata
- Authors
- Mouchlis, V. D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A. G., Aidinis, V., Lynch, I., Greco, D., & Melagraki, G.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-02-07
- Volume
- 22
- Issue
- 4
- Pages
- 1676
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3127347132
- Cited by
- 353
- References
- 146
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.